TrialsgrambetaRCTs are beautiful

DeRubeis-Hollon

2005

Cognitive Therapy vs Medications in Moderate-to-Severe Depression

In 240 outpatients with moderate-to-severe MDD, 16 weeks of cognitive therapy matched response and protected against relapse after taper compared with paroxetine or pill placebo.

Result

Primary endpoint: HRSD response at 16 wk and 12-month relapse

Acute response 58% (CT) vs 58% (paroxetine) vs 25% (placebo). After withdrawal, relapse 31% (CT) vs 76% (medication taper).

Original publication
Subtopic
CBT vs pharma
Design
RCT + 12-month continuation, USA
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
DeRubeis RJ, et al. Arch Gen Psychiatry. 2005;62(4):409-416.doi 10.1001/archpsyc.62.4.409

Discussion & critique

First trial to show CT can match antidepressants in severe MDD and to deliver a durable post-treatment effect.